Chiglitazar ameliorates dehydroepiandrosterone-induced polycystic ovary syndrome in rats
Chiglitazar significantly improved ovulation in rats with PCOS and may be a potential novel therapeutic strategy for PCOS.
Authors
- Fuzhen Zhao (ORCID: https://orcid.org/0000-0002-4630-4558)
- C. Fang (ORCID: https://orcid.org/0009-0002-7438-2390)
- Wei Cui (ORCID: https://orcid.org/0000-0002-2600-1330)
- Cheng Zhang (ORCID: https://orcid.org/0000-0003-3672-6543)
- Yuanyuan Luo (ORCID: https://orcid.org/0000-0002-3826-3637)
Institutions
- Chongqing University (CN)
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Three Gorges Central Hospital (CN)
- Chongqing Three Gorges University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Journal of Ovarian Research
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1186/s13048-024-01554-6
- Citations
- 2
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- National Natural Science Foundation of China